Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 5, Issue 1, Pages 70-74Publisher
WILEY
DOI: 10.1111/j.1538-7836.2006.02301.x
Keywords
cancer; microvesicles; thrombosis; tissue factor; Trousseau's syndrome
Categories
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064796, R01HL065500] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01 HL065500-06, R01 HL065500-05A2, R01HL64796, R01 HL064796, R01 HL065500] Funding Source: Medline
Ask authors/readers for more resources
Background: Trousseau's syndrome is a prothrombotic state associated with malignancy that is poorly understood pathophysiologically. Methods and Results: Here we report studies on the blood of a 55-year-old man with giant-cell lung carcinoma who developed a severe form of Trousseau's syndrome. His clinical course was dominated by an extremely hypercoagulable state. Despite receiving potent antithrombotic therapy, he suffered eleven major arterial and venous thrombotic events over a 5 month period. We examined the patient's blood for tissue factor (TF), the major initiator of coagulation, and found its concentration in his plasma to be forty-one-fold higher than the mean concentration derived from testing of 16 normal individuals. Conclusion: Almost all of the TF in the patient's plasma was associated with cell-derived microvesicles, likely shed by the cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available